JaLCDOI |
10.18926/AMO/54590
|
フルテキストURL |
70_5_331.pdf
|
著者 |
Iida, Atsuyoshi|
Nosaka, Nobuyuki|
Yumoto, Tetsuya|
Knaup, Emily|
Naito, Hiromichi|
Nishiyama, Chihiro|
Yamakawa, Yasuaki|
Tsukahara, Kohei|
Terado, Michihisa|
Sato, Keiji|
Ugawa, Toyomu|
Nakao, Atsunori|
|
抄録 |
In recent years, it has become evident that molecular hydrogen is a particularyl effective treatment for various disease models such as ischemia-reperfusion injury; as a result, research on hydrogen has progressed rapidly. Hydrogen has been shown to be effective not only through intake as a gas, but also as a liquid medication taken orally, intravenously, or locally. Hydrogenʼs effectiveness is thus multifaceted. Herein we review the recent research on hydrogen-rich water, and we examine the possibilities for its clinical application. Now that hydrogen is in the limelight as a gaseous signaling molecule due to its potential ability to inhibit oxidative stress signaling, new research developments are highly anticipated.
|
キーワード |
hydrogen
antioxidant effect
medical gas
gaseous signaling molecule
clinical tests
|
Amo Type |
Review
|
出版物タイトル |
Acta Medica Okayama
|
発行日 |
2016-10
|
巻 |
70巻
|
号 |
5号
|
出版者 |
Okayama University Medical School
|
開始ページ |
331
|
終了ページ |
337
|
ISSN |
0386-300X
|
NCID |
AA00508441
|
資料タイプ |
学術雑誌論文
|
言語 |
英語
|
著作権者 |
CopyrightⒸ 2016 by Okayama University Medical School
|
論文のバージョン |
publisher
|
査読 |
有り
|
PubMed ID |
27777424
|
Web of Science KeyUT |
000388098700001
|